Six Degrees of a Drug Deal: Endo Battles Valeant for Salix

I just love it when a drug industry acquisition starts sounding like a round from the drinking game “six degrees of separation.” The Wall Street Journal is reporting that yet another drug maker is looking to wrest a company from the clutches of Valeant Pharmaceuticals (VRX). Endo International (ENDP) is bidding for Salix Pharmaceticals (SLXP), [...]